ArticleFrontiers in oncology2022

The Combination of Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Delays KMT2A-Rearranged Leukemia Progression.

Lin Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.